 BERKELEY HEIGHTS, N.J., Sept. 21, 2022 GLOBE NEWSWIRE -- Cyclacel Pharmaceuticals, Inc. NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company, a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that management will participate in Ladenburg Thalmanns 2022 Healthcare Conference on September 29, 2022 at the Sofitel New York. 